13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q2 2024. See the latest, Q3 2026 →

Reported value

$3.63B

−0.5% on the quarter before

Positions

24

5 new, 3 sold out

Top 10

76.6%

of the value

Est. gain

−$175.2M

on stocks held all quarter

Est. return

−6.1%

on those stocks since Q1 2024

Filed

Aug 13, 2024

On SEC EDGAR ↗

Positions as of Jun 30, 2024, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.

Liberty Global Ltd21%
Willis Towers Watson Plc Ltd12%
Crh Plc8.7%
Fidelity Natl Information Sv7.3%
Clarivate Plc6.1%
Alphabet5.4%
Viasat Inc4.8%
Humana Inc4.3%
Jazz Pharmaceuticals Plc3.7%
Wesco Intl Inc3.5%
Liberty Global Ltd3.5%
Outbrain Inc2.8%
Solventum Corp2.6%
Willscot Mobil Mini Hldng Co2.6%
Eagle Matls Inc2.0%
Fortrea Hldgs Inc2.0%
Jacobs Solutions Inc1.9%
Herbalife Ltd1.5%
Gds Hldgs Ltd1.1%
Theravance Biopharma Inc1.0%
Capri Holdings Limited0.9%
0.6%
0.5%

Largest buys

Since Q1 2024, sized at quarter-end prices.

  1. Humana Inc~$156.9MNew, 0.0% → 4.3% of the portfolio+420,000 shares
  2. Crh Plc~$113.7MAdded, 6.4% → 8.7% of the portfolio+1,517,059 shares
  3. Solventum Corp~$96.2MNew, 0.0% → 2.6% of the portfolio+1,820,000 shares
  4. Wesco Intl Inc~$94.7MAdded, 1.0% → 3.5% of the portfolio+597,276 shares
  5. Willscot Mobil Mini Hldng Co~$93.0MNew, 0.0% → 2.6% of the portfolio+2,470,000 shares
  6. Fortrea Hldgs Inc~$66.2MAdded, 0.3% → 2.0% of the portfolio+2,836,563 shares
  7. Clarivate Plc~$47.4MAdded, 6.2% → 6.1% of the portfolio+8,331,233 shares
  8. Jazz Pharmaceuticals Plc~$47.0MAdded, 2.7% → 3.7% of the portfolio+440,552 shares
  9. Capri Holdings Limited~$33.1MNew, 0.0% → 0.9% of the portfolio+1,000,000 shares
  10. Herbalife Ltd~$29.9MAdded, 0.6% → 1.5% of the portfolio+2,879,603 shares

Largest sells

Since Q1 2024, sized at quarter-end prices.

  1. Alphabet~$346.3MCut, 12.3% → 5.4% of the portfolio−1,888,064 shares
  2. Fidelity Natl Information Sv~$156.0MCut, 11.3% → 7.3% of the portfolio−2,069,715 shares
  3. Liberty Media Corp Del~$73.0MCut, 3.5% → 0.6% of the portfolio−3,292,432 shares
  4. Liberty Media Corp Del~$46.0MCut, 2.2% → 0.4% of the portfolio−2,077,462 shares
  5. Warner Bros Discovery Inc~$32.4MSold out, 0.9% → 0.0% of the portfolio−3,713,930 shares
  6. Theravance Biopharma Inc~$20.3MCut, 1.6% → 1.0% of the portfolio−2,394,105 shares
  7. Viasat Inc~$16.1MCut, 7.4% → 4.8% of the portfolio−1,271,474 shares
  8. Altice Usa Inc~$12.5MSold out, 0.3% → 0.0% of the portfolio−4,774,615 shares
  9. SoundHound AI~$5.6MSold out, 0.2% → 0.0% of the portfolio−1,130,636 shares
  10. Jacobs Solutions Inc~$1.8MCut, 2.1% → 1.9% of the portfolio−12,568 shares

Holdings

As of Jun 30, 2024; changes in shares since Mar 31, 2024.

Positions, sorted by share of the portfolio
HoldingValue
Liberty Global LtdCOM CL C · shares 0% · price +1.2%20.8%$755.3M+$8.9M
Willis Towers Watson Plc LtdSHS · shares +6.2% · price −4.7%11.9%$433.2M−$20.0M
Crh PlcORD · shares +56% · price −13.1%8.7%$316.9M−$30.6M
Fidelity Natl Information SvCOM · shares −37% · price +1.6%7.3%$264.5M+$4.1M
Clarivate PlcORD SHS · shares +27% · price −23.4%6.1%$221.5M−$53.2M
AlphabetCAP STK CL C · shares −64% · price +20.5%5.4%$196.2M+$33.3M
Viasat IncCOM · shares −8.5% · price −29.8%4.8%$174.7M−$74.2M
Humana IncCOM · shares New4.3%$156.9M—
Jazz Pharmaceuticals PlcSHS USD · shares +53% · price −11.4%3.7%$136.0M−$11.4M
Wesco Intl IncCOM · shares +290% · price −7.4%3.5%$127.3M−$2.6M
Liberty Global LtdCOM CL A · shares 0% · price +3.0%3.5%$125.4M+$3.7M
Outbrain IncNOTE 2.950% 7/2 · shares 0% · price +0.7%2.8%$103.3M—
Solventum CorpCOM SHS · shares New2.6%$96.2M—
Willscot Mobil Mini Hldng CoCOM CL A · shares New2.6%$93.0M—
Eagle Matls IncCOM · shares +31% · price −20.0%2.0%$74.4M−$14.2M
Fortrea Hldgs IncCOMMON STOCK · shares +934% · price −41.9%2.0%$73.3M−$5.1M
Jacobs Solutions IncCOM · shares −2.5% · price −9.1%1.9%$69.0M−$6.9M
Herbalife LtdCOM SHS · shares +128% · price +3.4%1.5%$53.2M+$763,827
Gds Hldgs LtdSPONSORED ADS · shares +63% · price +39.7%1.1%$39.5M+$6.9M
Theravance Biopharma IncCOM · shares −36% · price −5.5%0.98%$35.6M−$2.1M
Capri Holdings LimitedSHS · shares New0.91%$33.1M—
Liberty Media Corp DelCOM LBTY SRM S C · shares −76% · price −25.4%0.65%$23.5M−$8.0M
Verisign IncCOM · shares New0.52%$18.8M—
Liberty Media Corp DelCOM LBTY SRM S A · shares −78% · price −25.4%0.37%$13.3M−$4.5M
Total 24 positions100%$3.63B−$175.2M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2024 to Q2 2024: 18 stocks held throughout, down $175.2M (−6.1%).

  1. Alphabet+$33.3M+20%
  2. Liberty Global Ltd+$8.9M+1%
  3. Gds Hldgs Ltd+$6.9M+40%
  4. Fidelity Natl Information Sv+$4.1M+2%
  5. Liberty Global Ltd+$3.7M+3%
  6. Eagle Matls Inc−$14.2M−20%
  7. Willis Towers Watson Plc Ltd−$20.0M−5%
  8. Crh Plc−$30.6M−13%
  9. Clarivate Plc−$53.2M−23%
  10. Viasat Inc−$74.2M−30%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free